OpenAI introduced GPT-Rosalind on Thursday, a purpose-built artificial intelligence model that the company says increases biology knowledge and supports scientific research activities. Named after the 20th-century British scientist Rosalind Franklin, the model is aimed at researchers working in biochemistry, drug discovery and translational medicine.
OpenAI describes GPT-Rosalind as a tool to support multi-step research tasks such as evidence synthesis, hypothesis generation and experimental planning. In a blog post, the company said the model is designed to help researchers accelerate the early stages of discovery by assisting with those foundational activities.
According to materials presented in a press briefing, researchers will be able to use GPT-Rosalind to interrogate databases, read and interpret recent scientific papers, operate other scientific tools and propose new experiments. The model was developed using OpenAI's newest internal models as a base, the company said.
OpenAI is making GPT-Rosalind available as a research preview inside ChatGPT, in Codex and through the API for qualified customers, using what it describes as a trusted access deployment structure. In parallel, the company said it is launching a free Life Sciences research plugin for Codex that connects scientists to more than 50 scientific tools and data sources.
The company stated it is working with a set of customers, naming Amgen, Moderna and Thermo Fisher Scientific among organizations that will apply GPT-Rosalind across their research workflows. OpenAI emphasized the model's role in facilitating early-stage research activities rather than offering definitive scientific conclusions.
The announcement of GPT-Rosalind follows recent product activity from the company, including the unveiling on Tuesday of GPT-5.4-Cyber, a variant of its newest flagship model that has been fine-tuned for defensive cybersecurity work. The release came in close timing to announcements from other firms developing frontier AI models.
While the new model and supporting tools are aimed at accelerating research, OpenAI framed GPT-Rosalind primarily as a research-oriented capability currently available to qualified users as a preview. The company positioned the launch as part of a broader push to deepen its footprint in life sciences research and to connect computational tools and data sources for scientific workflows.